Skip to content

Exploration of dialysis modalities in patients with end-stage renal combined ejection fraction nonconserved heart failure

Exploration of dialysis modalities in patients with end-stage renal combined ejection fraction nonconserved heart failure

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062129
Enrollment
Unknown
Registered
2022-07-24
Start date
2022-07-24
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ESRD with HFrEF and HFmrEF

Interventions

hemodialysis group :hemodialysis therapy
peritoneal dialysis group:peritoneal dialysis therapy

Sponsors

Department of Nephrology,the second hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.confirmed diagnosis of chronic kidney disease stage 5. 2.Diagnostic criteria for HFrEF and HFmrEF based on the 2016 European Failure Guidelines and in conjunction with the 2021 European Heart Failure Guidelines. 3.New York Heart Attack (NYHA) class I-IV. 4.Patients undergoing hemodialysis or abdominal dialysis for the first time in our hospital. 5.Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with combined malignant tumors, hematologic diseases, uncontrolled neuroendocrine system and psychiatric system disorders. 2.Severe malnutrition such as serum albumin <20g/L and hemoglobin <30g/L 3.Recent (within 90 d) combined acute myocardial infarction, cerebral infarction, cerebral hemorrhage and other serious cardiovascular and cerebrovascular events. 4.Patients with congenital heart disease, hypertrophic obstructive type cardiomyopathy, acute myocarditis, restrictive cardiomyopathy, large vessel aneurysm, aortic coarctation, undiagnosed rheumatic and senile degenerative heart valve disease

Design outcomes

Primary

MeasureTime frame
Renal function index;Cardiac function index;NYHA classification;Biochemical detection;Number of rehospitalizations for heart failure;

Countries

China

Contacts

Public ContactCui Wenpeng

The second hospital of Jilin University

wenpengcui@163.com+86 13504316157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026